Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jennerex Biotherapeutics

Clinical trials sponsored by Jennerex Biotherapeutics, explained in plain language.

Virus injection targets liver tumors in early trial

Disease control Completed

This early-phase study tested a new treatment called JX-594, a modified virus injected directly into liver tumors. The main goal was to find a safe dose and check for side effects in 14 patients with advanced liver cancer that had not responded to standard treatments. The study f…

Phase: PHASE1 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control

Last updated May 26, 2026 10:55 UTC